Dr. Mukesh Thawani, M.D

NPI: 1174716427
Total Payments
$834.34
2024 Payments
$50.47
Companies
24
Transactions
38
Medicare Patients
2,063
Medicare Billing
$322,601

Payment Breakdown by Category

Food & Beverage$795.56 (95.4%)
Education$38.78 (4.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $795.56 36 95.4%
Education $38.78 2 4.6%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $130.84 6 $0 (2023)
Jazz Pharmaceuticals Inc. $115.00 1 $0 (2017)
AstraZeneca Pharmaceuticals LP $63.75 3 $0 (2021)
Lundbeck LLC $51.62 3 $0 (2020)
Takeda Pharmaceuticals U.S.A., Inc. $50.17 2 $0 (2021)
GENZYME CORPORATION $40.22 2 $0 (2023)
OPKO Pharmaceuticals, LLC $38.78 2 $0 (2021)
Horizon Therapeutics plc $34.48 2 $0 (2023)
Daiichi Sankyo Inc. $31.84 2 $0 (2022)
Amgen Inc. $25.37 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $50.47 2 Amgen Inc. ($25.37)
2023 $81.26 3 Janssen Pharmaceuticals, Inc ($42.13)
2022 $48.35 3 AKEBIA THERAPEUTICS INC ($22.64)
2021 $232.95 11 Takeda Pharmaceuticals U.S.A., Inc. ($50.17)
2020 $203.58 12 Janssen Pharmaceuticals, Inc ($65.04)
2019 $14.11 1 Lundbeck LLC ($14.11)
2018 $72.80 4 GENZYME CORPORATION ($22.13)
2017 $130.82 2 Jazz Pharmaceuticals Inc. ($115.00)

All Payment Transactions

38 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
07/26/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $25.10 General
Category: Cardio-renal
07/17/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $25.37 General
Category: Inflammation/Rare Disease
08/31/2023 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage In-kind items and services $18.09 General
Category: Genetic Disease
08/25/2023 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $21.04 General
Category: KRYSTEXXA
02/23/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $42.13 General
Category: Cardiovascular & Metabolism
10/20/2022 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $12.42 General
Category: Cardiovascular
03/10/2022 AKEBIA THERAPEUTICS INC Auryxia (Drug) Food and Beverage In-kind items and services $22.64 General
Category: Nephrology
01/11/2022 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $13.29 General
Category: Iron Deficiency Anemia
09/03/2021 Eisai Inc. Dayvigo (Drug) Food and Beverage Cash or cash equivalent $17.29 General
Category: Neurology
07/16/2021 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $24.52 General
Category: NEUROSCIENCE
07/02/2021 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $21.61 General
Category: NEPHROLOGY
06/21/2021 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $25.65 General
Category: INTERNAL MEDICINE
06/03/2021 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $18.55 General
Category: Iron Deficiency Anemia
04/01/2021 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $17.85 General
Category: Cardiovascular
02/12/2021 Travere Therapeutics, Inc. Thiola (Drug) Food and Beverage In-kind items and services $20.00 General
Category: Kidney Stones
02/09/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA Food and Beverage In-kind items and services $23.67 General
Category: Cardiovascular & Metabolism
02/03/2021 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $23.18 General
Category: Cardiovascular and Metabolism
01/19/2021 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $23.46 General
Category: IMMUNOLOGY
01/12/2021 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $17.17 General
Category: NEPHROLOGY
12/07/2020 Alnylam Pharmaceuticals Inc. OXLUMO (Drug) Food and Beverage In-kind items and services $18.24 General
Category: Genetic Disease
11/21/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $16.22 General
Category: Cardiovascular & Metabolism
11/11/2020 Lundbeck LLC NORTHERA (Drug) Food and Beverage Cash or cash equivalent $16.27 General
Category: NEUROLOGY
10/15/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $11.62 General
Category: Cardiovascular & Metabolism
09/02/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.89 General
Category: Cardiovascular & Metabolism
08/24/2020 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $17.68 General
Category: Phosphate binder for ESRD

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 281 985 $357,715 $76,725
2022 8 553 1,100 $475,845 $78,634
2021 7 484 869 $343,036 $74,150
2020 11 745 1,192 $363,084 $93,092
Total Patients
2,063
Total Services
4,146
Medicare Billing
$322,601
Procedure Codes
31

All Medicare Procedures & Services

31 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 124 471 $212,321 $43,592 20.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 56 335 $83,007 $21,007 25.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 64 64 $35,926 $5,584 15.5%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 16 94 $13,941 $3,680 26.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 21 21 $12,521 $2,862 22.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 207 520 $245,111 $41,457 16.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 98 262 $86,118 $14,177 16.5%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 135 138 $77,495 $11,274 14.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 19 20 $15,217 $3,071 20.2%
99226 Follow-up observation care per day, typically 35 minutes Facility 2022 27 35 $17,497 $2,665 15.2%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 28 86 $14,586 $2,562 17.6%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 18 18 $12,615 $2,316 18.4%
99217 Hospital observation care on day of discharge Facility 2022 21 21 $7,206 $1,111 15.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 176 480 $174,458 $39,957 22.9%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 115 120 $47,223 $10,082 21.4%
99220 Hospital observation care, typically 70 minutes Facility 2021 58 60 $39,025 $8,276 21.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 46 111 $34,486 $6,339 18.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 31 31 $23,694 $4,877 20.6%
99226 Subsequent observation care, typically 35 minutes per day Facility 2021 26 35 $16,332 $2,779 17.0%
99217 Hospital observation care on day of discharge Facility 2021 32 32 $7,819 $1,839 23.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 169 394 $131,323 $33,635 25.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 136 318 $68,807 $18,403 26.7%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 118 121 $41,900 $10,642 25.4%
99220 Hospital observation care, typically 70 minutes Facility 2020 59 59 $36,386 $8,337 22.9%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 44 44 $29,869 $7,253 24.3%

About Dr. Mukesh Thawani, M.D

Dr. Mukesh Thawani, M.D is a Internal Medicine healthcare provider based in Roseburg, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174716427.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mukesh Thawani, M.D has received a total of $834.34 in payments from pharmaceutical and medical device companies, with $50.47 received in 2024. These payments were reported across 38 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($795.56).

As a Medicare-enrolled provider, Thawani has provided services to 2,063 Medicare beneficiaries, totaling 4,146 services with total Medicare billing of $322,601. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Hospitalist, Internal Medicine
  • Location Roseburg, OR
  • Active Since 08/21/2007
  • Last Updated 09/26/2018
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1174716427

Products in Payments

  • XARELTO (Drug) $130.84
  • Xyrem (Drug) $115.00
  • LOKELMA (Drug) $63.75
  • KRYSTEXXA (Biological) $59.85
  • NORTHERA (Drug) $51.62
  • RAYALDEE (Drug) $38.78
  • INJECTAFER (Drug) $31.84
  • GATTEX (Drug) $25.65
  • Kerendia (Drug) $25.10
  • TRINTELLIX (Drug) $24.52
  • BENLYSTA (Biological) $23.46
  • Auryxia (Drug) $22.64
  • FABRY-DISEASE (Drug) $22.13
  • Thiola (Drug) $20.00
  • JYNARQUE (Drug) $18.24
  • OXLUMO (Drug) $18.24
  • FABRAZYME (Biological) $18.09
  • Vascepa (Drug) $17.85
  • Velphoro (Drug) $17.68
  • Dayvigo (Drug) $17.29

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Roseburg